{"hands_on_practices": [{"introduction": "Effective management of hereditary syndromes like Multiple Endocrine Neoplasia (MEN) begins with accurate diagnosis. This practice applies Bayes’ theorem to a common clinical scenario: interpreting a genetic test result for an at-risk family member. By working through this problem ([@problem_id:4674629]), you will master the calculation of posterior probability, transforming a pre-test suspicion (prior probability $p$) into a quantitative post-test risk using the test's sensitivity $s$ and specificity $c$.", "problem": "A surgical team is planning the timing of prophylactic interventions for a family with Multiple Endocrine Neoplasia type 1 (MEN1) based on germline genetic testing. An asymptomatic adult first-degree relative in a known MEN1 kindred has a prior probability $p$ of MEN1 of $0.25$ based on pedigree analysis and established penetrance estimates. The germline test for the MEN1 pathogenic variant has sensitivity $s$ of $0.98$ and specificity $c$ of $0.99$. The patient’s test returns positive.\n\nUsing the fundamental definitions of sensitivity and specificity and Bayes’ theorem, derive the posterior probability $P(\\text{MEN1} \\mid +)$ after a positive result expressed purely in terms of $s$, $c$, and $p$, and then evaluate it for the given values. Round your final numerical answer to four significant figures and express it as a decimal fraction with no percentage sign.", "solution": "The problem is valid. It is a well-posed application of Bayesian probability theory to a realistic problem in medical diagnostics, using scientifically sound principles and clearly defined, consistent data.\n\nThe objective is to calculate the posterior probability of a patient having Multiple Endocrine Neoplasia type 1 (MEN1) given a positive genetic test result. We are provided with the prior probability, and the test's sensitivity and specificity.\n\nFirst, let us define the events and probabilities based on the problem statement:\n- Let $M$ be the event that the patient has MEN1.\n- Let $M^c$ be the event that the patient does not have MEN1.\n- Let $+$ be the event that the test result is positive.\n\nThe given information can be expressed in probabilistic terms:\n- The prior probability of having MEN1 is $P(M) = p = 0.25$.\n- The prior probability of not having MEN1 is $P(M^c) = 1 - P(M) = 1 - p$.\n- The sensitivity of the test is the probability of a positive result given the patient has MEN1. This is the true positive rate: $P(+ \\mid M) = s = 0.98$.\n- The specificity of the test is the probability of a negative result given the patient does not have MEN1. This is the true negative rate: $P(- \\mid M^c) = c = 0.99$.\n\nWe are asked to find the posterior probability $P(M \\mid +)$. We will use Bayes' theorem for this derivation. Bayes' theorem states:\n$$P(M \\mid +) = \\frac{P(+ \\mid M) P(M)}{P(+)}$$\n\nThe denominator, $P(+)$, is the total probability of a positive test result. It can be calculated using the law of total probability, summing over the two mutually exclusive scenarios: the patient has MEN1, or the patient does not have MEN1.\n$$P(+) = P(+ \\mid M) P(M) + P(+ \\mid M^c) P(M^c)$$\n\nTo use this formula, we need the term $P(+ \\mid M^c)$, which is the probability of a positive test given the patient does not have the disease (the false positive rate). This can be derived from the specificity, $c$. Since a test result is either positive or negative, for a patient without MEN1, the sum of a true negative and a false positive probability must be $1$:\n$$P(+ \\mid M^c) + P(- \\mid M^c) = 1$$\n$$P(+ \\mid M^c) = 1 - P(- \\mid M^c) = 1 - c$$\n\nNow we can substitute our defined symbols into the expression for the total probability $P(+)$:\n$$P(+) = (s)(p) + (1 - c)(1 - p)$$\n\nFinally, substituting this expression for $P(+)$ back into Bayes' theorem gives the desired posterior probability, $P(M \\mid +)$, purely in terms of $s$, $c$, and $p$:\n$$P(M \\mid +) = \\frac{s \\cdot p}{s \\cdot p + (1 - c)(1 - p)}$$\nThis is the general formula for the posterior probability.\n\nNow, we will evaluate this expression using the numerical values provided in the problem:\n- $p = 0.25$\n- $s = 0.98$\n- $c = 0.99$\n\nFrom these, we can also determine:\n- $1 - p = 1 - 0.25 = 0.75$\n- $1 - c = 1 - 0.99 = 0.01$\n\nWe calculate the terms in the formula:\nThe numerator, which represents the probability of a true positive result in the population cohort, is:\n$$s \\cdot p = (0.98)(0.25) = 0.245$$\n\nThe denominator is the sum of the probability of a true positive and the probability of a false positive. The false positive term is:\n$$(1 - c)(1 - p) = (0.01)(0.75) = 0.0075$$\n\nThe total probability of a positive test is:\n$$P(+) = s \\cdot p + (1-c)(1-p) = 0.245 + 0.0075 = 0.2525$$\n\nNow, we can compute the posterior probability:\n$$P(M \\mid +) = \\frac{0.245}{0.2525}$$\nTo facilitate calculation, we can express this as a fraction of integers:\n$$P(M \\mid +) = \\frac{2450}{2525} = \\frac{98}{101}$$\n\nConverting this fraction to a decimal gives:\n$$P(M \\mid +) \\approx 0.9702970297...$$\n\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $9$, $7$, $0$, and $2$. The fifth significant figure is $9$, which is $5$ or greater, so we round up the fourth digit.\n$$P(M \\mid +) \\approx 0.9703$$\nThus, after a positive test, the probability that this individual has MEN1 increases from the prior probability of $25\\%$ to approximately $97.03\\%$.", "answer": "$$\\boxed{0.9703}$$", "id": "4674629"}, {"introduction": "Once a diagnosis of Multiple Endocrine Neoplasia type 2 (MEN2)-associated medullary thyroid carcinoma is made, the next critical step is planning the extent of surgery. This exercise ([@problem_id:4674598]) demonstrates how to build and apply a logistic regression model to estimate the risk of nodal metastasis based on preoperative calcitonin levels. You will then use decision theory to determine a formal threshold for performing a lateral neck dissection, providing a data-driven approach to balancing the risks of surgery against the risks of undertreatment.", "problem": "A patient with Multiple Endocrine Neoplasia type 2 (MEN2) and biopsy-proven medullary thyroid carcinoma (MTC) presents with a basal calcitonin concentration $C_0 = 120$ pg/mL. For preoperative surgical planning in general surgery, the decision to add lateral compartment neck dissection hinges on the estimated probability of occult lateral nodal metastasis. Assume that the probability $p(C)$ of occult lateral nodal metastasis given basal calcitonin $C$ (in pg/mL) follows a canonical logistic model on the natural logarithm scale, anchored by empirically established calibration points from multi-institutional datasets: at $C_1 = 30$ pg/mL the probability is $p_1 = 0.20$, and at $C_2 = 200$ pg/mL the probability is $p_2 = 0.75$. Using a standard decision-theoretic framework, let the normalized expected harm (loss) associated with an unnecessary lateral neck dissection be $L_{\\text{LND}} = 0.10$, and the normalized expected harm associated with a missed occult lateral nodal metastasis (necessitating reoperation and risking disease progression) be $L_{\\text{miss}} = 0.30$. \n\nStarting from the definitions of odds, log-odds, and the logistic link, and from the principle of minimizing expected loss, do the following:\n1. Derive the logistic parameters $\\alpha$ and $\\beta$ consistent with the two calibration points on $\\ln(C)$.\n2. Compute the probability $p(C_0)$ for $C_0 = 120$ pg/mL.\n3. Derive the decision threshold $p^{\\ast}$ at which the expected loss of performing lateral neck dissection equals that of deferring it, and determine whether lateral compartment dissection is warranted at $C_0$ by comparing $p(C_0)$ to $p^{\\ast}$.\n\nExpress the final probability as a decimal (not a percentage) and round it to four significant figures. Report your final result as a row matrix $\\begin{pmatrix} p  d \\end{pmatrix}$, where $p$ is the rounded probability and $d$ is the decision indicator with $d = 1$ if lateral neck dissection is warranted and $d = 0$ otherwise. No units are required for the final answer.", "solution": "The problem is valid as it is scientifically grounded in standard statistical modeling (logistic regression) and decision theory, is well-posed with sufficient data for a unique solution, and is stated in objective, formal language.\n\nThe problem requires a three-part solution:\n1.  Derive the parameters of the logistic model.\n2.  Calculate the probability of metastasis for the given patient.\n3.  Determine the optimal surgical decision based on a loss-minimization framework.\n\n**Part 1: Derivation of the Logistic Model Parameters**\n\nThe problem states that the probability $p(C)$ of occult lateral nodal metastasis follows a logistic model on the natural logarithm of the calcitonin concentration $C$. The logistic model relates the predictor variable, $\\ln(C)$, to the log-odds (logit) of the probability $p$:\n$$ \\text{logit}(p(C)) = \\ln\\left(\\frac{p(C)}{1 - p(C)}\\right) = \\alpha + \\beta \\ln(C) $$\nHere, $\\alpha$ and $\\beta$ are the parameters to be determined. We are given two calibration points:\n1.  $C_1 = 30$ pg/mL, with probability $p_1 = 0.20$.\n2.  $C_2 = 200$ pg/mL, with probability $p_2 = 0.75$.\n\nWe can use these two points to set up a system of two linear equations for $\\alpha$ and $\\beta$.\n\nFor the first point, the log-odds are:\n$$ \\text{logit}(p_1) = \\ln\\left(\\frac{0.20}{1 - 0.20}\\right) = \\ln\\left(\\frac{0.20}{0.80}\\right) = \\ln(0.25) = \\ln\\left(\\frac{1}{4}\\right) = -\\ln(4) $$\nThe corresponding equation is:\n$$ -\\ln(4) = \\alpha + \\beta \\ln(30) \\quad (1) $$\n\nFor the second point, the log-odds are:\n$$ \\text{logit}(p_2) = \\ln\\left(\\frac{0.75}{1 - 0.75}\\right) = \\ln\\left(\\frac{0.75}{0.25}\\right) = \\ln(3) $$\nThe corresponding equation is:\n$$ \\ln(3) = \\alpha + \\beta \\ln(200) \\quad (2) $$\n\nTo solve for $\\beta$, we subtract equation $(1)$ from equation $(2)$:\n$$ \\ln(3) - (-\\ln(4)) = (\\alpha + \\beta \\ln(200)) - (\\alpha + \\beta \\ln(30)) $$\n$$ \\ln(3) + \\ln(4) = \\beta (\\ln(200) - \\ln(30)) $$\nUsing logarithm properties, $\\ln(a) + \\ln(b) = \\ln(ab)$ and $\\ln(a) - \\ln(b) = \\ln(a/b)$:\n$$ \\ln(12) = \\beta \\ln\\left(\\frac{200}{30}\\right) = \\beta \\ln\\left(\\frac{20}{3}\\right) $$\nSolving for $\\beta$:\n$$ \\beta = \\frac{\\ln(12)}{\\ln(20/3)} $$\n\nNow we can solve for $\\alpha$ by rearranging equation $(1)$:\n$$ \\alpha = -\\ln(4) - \\beta \\ln(30) $$\nSubstituting the expression for $\\beta$:\n$$ \\alpha = -\\ln(4) - \\frac{\\ln(12)}{\\ln(20/3)} \\ln(30) $$\n\n**Part 2: Calculation of Probability for $C_0 = 120$ pg/mL**\n\nWe now use the derived model to calculate the probability $p(C_0)$ for the patient with $C_0 = 120$ pg/mL. First, we compute the log-odds for $C_0$:\n$$ \\text{logit}(p(C_0)) = \\alpha + \\beta \\ln(120) $$\nSubstituting the expressions for $\\alpha$ and $\\beta$:\n$$ \\text{logit}(p(C_0)) = \\left(-\\ln(4) - \\frac{\\ln(12)}{\\ln(20/3)}\\ln(30)\\right) + \\left(\\frac{\\ln(12)}{\\ln(20/3)}\\right)\\ln(120) $$\n$$ \\text{logit}(p(C_0)) = -\\ln(4) + \\frac{\\ln(12)}{\\ln(20/3)} \\left(\\ln(120) - \\ln(30)\\right) $$\n$$ \\text{logit}(p(C_0)) = -\\ln(4) + \\frac{\\ln(12)}{\\ln(20/3)} \\ln\\left(\\frac{120}{30}\\right) $$\n$$ \\text{logit}(p(C_0)) = -\\ln(4) + \\frac{\\ln(12)}{\\ln(20/3)} \\ln(4) $$\nLet $L_0 = \\text{logit}(p(C_0))$. We have:\n$$ L_0 = \\ln(4) \\left(\\frac{\\ln(12)}{\\ln(20/3)} - 1\\right) = \\ln(4) (\\beta-1)$$\nTo find the numerical value, we compute $\\beta$:\n$$ \\beta = \\frac{\\ln(12)}{\\ln(20/3)} \\approx \\frac{2.484907}{1.897120} \\approx 1.309821 $$\nNow we compute $L_0$:\n$$ L_0 \\approx \\ln(4) (1.309821 - 1) = 1.386294 \\times 0.309821 \\approx 0.429533 $$\nTo find the probability $p(C_0)$ from the log-odds $L_0$, we use the inverse logistic function:\n$$ p(C_0) = \\frac{\\exp(L_0)}{1 + \\exp(L_0)} $$\n$$ p(C_0) \\approx \\frac{\\exp(0.429533)}{1 + \\exp(0.429533)} \\approx \\frac{1.53653}{1 + 1.53653} \\approx \\frac{1.53653}{2.53653} \\approx 0.60578 $$\nRounding to four significant figures as requested, we get:\n$$ p(C_0) \\approx 0.6058 $$\n\n**Part 3: Derivation of Decision Threshold and Final Decision**\n\nWe need to decide whether to perform lateral neck dissection (LND) or to defer it. The decision is based on minimizing the expected harm (loss). Let $p$ be the true probability of metastasis. The two actions have the following expected losses:\n-   **Perform LND**: Loss is incurred only if there is no metastasis (an unnecessary surgery). The expected loss is $E_{\\text{LND}}(p) = L_{\\text{LND}} \\times (1-p)$.\n-   **Defer LND**: Loss is incurred only if metastasis is present (a missed diagnosis). The expected loss is $E_{\\text{defer}}(p) = L_{\\text{miss}} \\times p$.\n\nThe given loss values are $L_{\\text{LND}} = 0.10$ and $L_{\\text{miss}} = 0.30$.\nThe decision threshold, $p^{\\ast}$, is the probability at which the expected losses of both actions are equal:\n$$ E_{\\text{LND}}(p^{\\ast}) = E_{\\text{defer}}(p^{\\ast}) $$\n$$ L_{\\text{LND}} (1-p^{\\ast}) = L_{\\text{miss}} p^{\\ast} $$\n$$ 0.10 (1-p^{\\ast}) = 0.30 p^{\\ast} $$\n$$ 0.10 - 0.10 p^{\\ast} = 0.30 p^{\\ast} $$\n$$ 0.10 = 0.40 p^{\\ast} $$\n$$ p^{\\ast} = \\frac{0.10}{0.40} = 0.25 $$\n\nThe decision rule is as follows:\n-   If $p(C)  p^{\\ast}$, then $E_{\\text{defer}}(p)  E_{\\text{LND}}(p)$. To minimize expected loss, we should choose the action with the lower loss, which is to perform LND.\n-   If $p(C)  p^{\\ast}$, then $E_{\\text{LND}}(p)  E_{\\text{defer}}(p)$. We should defer LND.\n\nFor the patient with $C_0=120$ pg/mL, we calculated $p(C_0) \\approx 0.6058$. We compare this to the threshold $p^{\\ast}$:\n$$ 0.6058  0.25 $$\nSince the patient's probability of metastasis is greater than the decision threshold, lateral compartment dissection is warranted to minimize the expected harm. The decision indicator is therefore $d=1$.\n\nThe final result is the probability $p(C_0)$ rounded to four significant figures and the decision indicator $d$.\n$p \\approx 0.6058$\n$d = 1$\nThe result is reported as a row matrix $\\begin{pmatrix} p  d \\end{pmatrix}$.", "answer": "$$\\boxed{\\begin{pmatrix} 0.6058  1 \\end{pmatrix}}$$", "id": "4674598"}, {"introduction": "Surgical success in Multiple Endocrine Neoplasia type 1 (MEN1)-related hyperparathyroidism often hinges on real-time intraoperative assessment. This problem ([@problem_id:4674634]) delves into the pharmacokinetic principles underlying intraoperative parathyroid hormone (IOPTH) monitoring. By modeling parathyroid hormone (PTH) clearance as a first-order kinetic process, you will derive the expected hormone drop after gland excision, gaining a fundamental understanding of how to interpret IOPTH data to confirm adequate resection.", "problem": "A patient with Multiple Endocrine Neoplasia (MEN) type 1 undergoes bilateral neck exploration with subtotal parathyroidectomy for multigland parathyroid hyperplasia. Intraoperative Parathyroid Hormone (IOPTH) monitoring is used to assess adequacy of resection. Before excision, the circulating parathyroid hormone concentration is at baseline steady state $P_{0}$, and the hyperfunctioning parathyroid glands together dominate production. One hyperfunctioning gland is excised at time $t=0$, and two hyperfunctioning glands remain in situ. Assume the following foundational facts:\n- Circulating parathyroid hormone (PTH) follows first-order, one-compartment clearance kinetics with plasma half-life $t_{1/2} = 4$ minutes, and the clearance rate constant is $k = \\ln(2)/t_{1/2}$.\n- At steady state, concentration is proportional to production, so removing a gland that contributed a fraction $f$ of the baseline $P_{0}$ instantaneously reduces the steady-state target concentration from $P_{0}$ to $(1 - f) P_{0}$, while clearance remains unchanged.\n- After the step change in production at $t=0$, the concentration trajectory $P(t)$ relaxes exponentially toward the new steady-state value.\n\nUsing these principles, derive the expected fractional drop in IOPTH at $t = 10$ minutes post-excision relative to baseline, expressed as a decimal fraction (for example, $0.50$ represents $50$ percent). Your final answer must be a single closed-form analytic expression in terms of $f$ only. No rounding is required; provide the exact expression as specified. Do not include a percent sign.", "solution": "The problem statement will first be subjected to a rigorous validation process.\n\n### Step 1: Extract Givens\n- **Patient Condition**: Multiple Endocrine Neoplasia (MEN) type $1$.\n- **Procedure**: Bilateral neck exploration with subtotal parathyroidectomy.\n- **Pathophysiology**: Multigland parathyroid hyperplasia.\n- **Monitoring**: Intraoperative Parathyroid Hormone (IOPTH) monitoring.\n- **Baseline State ($t0$)**: Circulating parathyroid hormone (PTH) concentration at steady state is $P_0$.\n- **Event at $t=0$**: One hyperfunctioning gland is excised. Two hyperfunctioning glands remain.\n- **Kinetic Model**: First-order, one-compartment clearance kinetics for PTH.\n- **Half-life**: Plasma half-life of PTH, $t_{1/2} = 4$ minutes.\n- **Rate Constant**: Clearance rate constant is $k = \\ln(2)/t_{1/2}$.\n- **Production Change**: The excised gland contributed a fraction $f$ of the baseline production. This instantaneously reduces the steady-state target concentration from $P_0$ to $(1 - f) P_0$.\n- **Concentration Trajectory**: After $t=0$, the concentration $P(t)$ relaxes exponentially toward the new steady-state value.\n- **Objective**: Derive the expected fractional drop in IOPTH at $t = 10$ minutes post-excision relative to baseline. The answer must be a single closed-form analytic expression in terms of $f$ only.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientific Grounding**: The problem is grounded in established principles of pharmacokinetics and endocrinology. The use of a first-order, one-compartment model for PTH clearance is a standard and scientifically accepted simplification. The specified half-life of $t_{1/2} = 4$ minutes is consistent with the known biological half-life of intact PTH (approximately $2-5$ minutes). The clinical scenario described (IOPTH monitoring during parathyroidectomy for MEN1) is a standard surgical practice. The problem is scientifically and factually sound.\n2.  **Well-Posedness**: The problem is well-posed. It provides a clear physical model (first-order kinetics), a defined initial state ($P(0) = P_0$), a defined change in the system (reduction of PTH production rate), and a specific, unambiguous quantity to calculate (fractional drop at $t=10$ min). All necessary parameters ($t_{1/2}$, $f$) are provided or are the variable in terms of which the answer should be expressed. The problem is self-contained and not under- or over-specified.\n3.  **Objectivity**: The problem is expressed in precise, objective, and scientific language. It is free of subjective claims or ambiguity.\n\n### Step 3: Verdict and Action\nThe problem is scientifically grounded, well-posed, and objective. It does not violate any of the invalidity criteria. Therefore, the problem is deemed **valid**. I will proceed with the solution.\n\nThe dynamics of the parathyroid hormone (PTH) concentration, $P(t)$, are described by a first-order linear differential equation. Let $S(t)$ be the effective production rate of PTH (in units of concentration per time) and $k$ be the first-order clearance rate constant. The governing equation is:\n$$\n\\frac{dP(t)}{dt} = S(t) - k P(t)\n$$\nFor $t  0$, the system is at a steady state with concentration $P_0$. At steady state, $\\frac{dP}{dt} = 0$, so the baseline production rate, $S_0$, must satisfy:\n$$\nS_0 = k P_0\n$$\nAt time $t=0$, a gland contributing a fraction $f$ of the total production is excised. This causes an instantaneous step reduction in the production rate. The new production rate, $S_{new}$, for $t \\ge 0$ is:\n$$\nS_{new} = (1 - f) S_0 = (1 - f) k P_0\n$$\nThe problem statement correctly notes that this new production rate corresponds to a new steady-state concentration, $P_{ss, new} = (1-f)P_0$.\n\nFor $t \\ge 0$, the differential equation for the PTH concentration becomes:\n$$\n\\frac{dP(t)}{dt} = S_{new} - k P(t) = (1 - f) k P_0 - k P(t)\n$$\nThis can be rewritten as a standard first-order linear ordinary differential equation:\n$$\n\\frac{dP(t)}{dt} + k P(t) = k(1-f)P_0\n$$\nThe general solution to this equation is the sum of the homogeneous solution, $P_h(t)$, and a particular solution, $P_p(t)$. The homogeneous equation is $\\frac{dP_h}{dt} + k P_h = 0$, which has the solution $P_h(t) = C \\exp(-kt)$ for some constant $C$. For the particular solution, we can assume a constant solution $P_p(t) = A$, which upon substitution yields $0 + kA = k(1-f)P_0$, so $A = (1-f)P_0$. This particular solution is the new steady-state concentration.\n\nThe general solution for $t \\ge 0$ is:\n$$\nP(t) = P_h(t) + P_p(t) = C \\exp(-kt) + (1-f)P_0\n$$\nTo find the constant $C$, we use the initial condition. The concentration of PTH in the blood cannot change instantaneously. Thus, the concentration just after excision at $t=0$ must be the same as the concentration just before, which is the baseline $P_0$.\n$$\nP(0) = P_0\n$$\nSubstituting this into the general solution:\n$$\nP(0) = C \\exp(-k \\cdot 0) + (1-f)P_0 = C + (1-f)P_0\n$$\nSetting $P(0) = P_0$ gives:\n$$\nP_0 = C + (1-f)P_0 \\implies C = P_0 - (1-f)P_0 = P_0 - P_0 + fP_0 = fP_0\n$$\nSubstituting the value of $C$ back into the general solution, we obtain the expression for PTH concentration for $t \\ge 0$:\n$$\nP(t) = f P_0 \\exp(-kt) + (1-f)P_0\n$$\nWe need to find the fractional drop in IOPTH at $t=10$ minutes relative to the baseline $P_0$. The fractional drop is defined as:\n$$\n\\text{Fractional Drop} = \\frac{P_0 - P(10)}{P_0} = 1 - \\frac{P(10)}{P_0}\n$$\nSubstituting the expression for $P(t)$:\n$$\n\\frac{P(10)}{P_0} = \\frac{f P_0 \\exp(-10k) + (1-f)P_0}{P_0} = f \\exp(-10k) + (1-f)\n$$\nTherefore, the fractional drop is:\n$$\n\\text{Fractional Drop} = 1 - \\left[ f \\exp(-10k) + (1-f) \\right] = 1 - f \\exp(-10k) - 1 + f = f - f \\exp(-10k)\n$$\nFactoring out $f$, we get:\n$$\n\\text{Fractional Drop} = f(1 - \\exp(-10k))\n$$\nThe problem provides the half-life $t_{1/2} = 4$ minutes and the relation $k = \\ln(2)/t_{1/2}$.\n$$\nk = \\frac{\\ln(2)}{4} \\text{ min}^{-1}\n$$\nNow we evaluate the term $\\exp(-10k)$:\n$$\n-10k = -10 \\left( \\frac{\\ln(2)}{4} \\right) = -\\frac{10}{4} \\ln(2) = -2.5 \\ln(2)\n$$\nUsing the identity $a \\ln(b) = \\ln(b^a)$:\n$$\n-10k = \\ln(2^{-2.5})\n$$\nSo, the exponential term is:\n$$\n\\exp(-10k) = \\exp(\\ln(2^{-2.5})) = 2^{-2.5} = 2^{-5/2}\n$$\nWe can simplify this term:\n$$\n2^{-5/2} = \\frac{1}{2^{5/2}} = \\frac{1}{\\sqrt{2^5}} = \\frac{1}{\\sqrt{32}} = \\frac{1}{\\sqrt{16 \\cdot 2}} = \\frac{1}{4\\sqrt{2}}\n$$\nTo rationalize the denominator:\n$$\n\\frac{1}{4\\sqrt{2}} = \\frac{1}{4\\sqrt{2}} \\cdot \\frac{\\sqrt{2}}{\\sqrt{2}} = \\frac{\\sqrt{2}}{8}\n$$\nSubstituting this back into the expression for the fractional drop:\n$$\n\\text{Fractional Drop} = f \\left(1 - \\frac{\\sqrt{2}}{8} \\right)\n$$\nThis can be written with a common denominator:\n$$\n\\text{Fractional Drop} = f \\left( \\frac{8 - \\sqrt{2}}{8} \\right)\n$$\nThis is the final, exact, closed-form analytic expression in terms of $f$ only.", "answer": "$$\\boxed{f \\left( \\frac{8-\\sqrt{2}}{8} \\right)}$$", "id": "4674634"}]}